Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Terremoto Biosciences, Inc. Clinical Trials Central Contact
CONTACT
Lead
Terremoto Biosciences Inc.
This is a first-in-human clinical trial that will evaluate the safety, tolerability, and pharmacokinetics (PK) of TER-2013 as a monotherapy and in combination with fulvestrant and to determine the maximum tolerated/administered dose and preliminary clinical activity. The study consists of two parts: Part 1-Dose Escalation and Part 2 -Dose Expansion.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted